Cardiac myxoma and its growth over 5 years in a patient with a history of multiple cerebrovascular events: a case report
DOI:
https://doi.org/10.18203/2320-6012.ijrms20250719Keywords:
Cardiac tumor, Myxoma, Cardiac tumorsAbstract
Cardiac tumors frequently present significant clinical, diagnostic, and therapeutic challenges. In many cases, a cardiac mass is detected incidentally and can represent benign or malignant processes, primary or secondary. Over 90% of primary cardiac tumors are benign (in adults, myxomas are most common, while in children, rhabdomyomas are more frequent). These tumors can be further classified as simple or complex based on the necessary treatment and may affect different chambers of the heart and the pericardium. Secondary or metastatic cardiac tumors are 30 times more common than primary neoplasms, with an incidence in autopsies ranging from 1.4% to 14%. Myxomas constitute approximately 50% of all benign cardiac tumors in adults. Most myxomas (over 80%) are located in the left atrium, with decreasing frequency in the right atrium, right ventricle, and left ventricle. We present the case of a 76-year-old woman who was found to have a left atrial mass identified on echocardiogram in 2019 as part of a cerebrovascular disease evaluation protocol. However, the patient did not attend follow-up. In December 2024, she was hospitalized for a lower respiratory tract infection, and during her admission, a new echocardiographic study showed tumor growth over 5 years.
Metrics
References
Li Y, Yang W, Liao S, Zuo H, Liu M. Cardiac myxomas as great imitators: a rare case series and review of the literature. Heart & Lung. 2022;52:182-9. DOI: https://doi.org/10.1016/j.hrtlng.2022.01.010
Rothenbuhler A, Stratakis CA. Clinical and molecular genetics of Carney complex. Best practice & research Clin Endocrinol & Metabol. 2010;24(3):389-99. DOI: https://doi.org/10.1016/j.beem.2010.03.003
Feghali EJ, Vasudeva R, Feghali E, Deutsch J. Large left atrial myxoma discovered during restaging of breast cancer. Kansas J Med. 2024;17:83. DOI: https://doi.org/10.17161/kjm.vol17.21274
Maleszewski JJ, Basso C, Bois MC, Glass C, Klarich KW, Leduc C, Padera RF, Tavora F. The 2021 WHO classification of tumors of the heart. J of Thoracic Oncol. 2022;17(4):510-8. DOI: https://doi.org/10.1016/j.jtho.2021.10.021
Saad EA, Mukherjee T, Gandour G, Fatayerji N, Rammal A, Samuel P, et al. Cardiac myxomas: causes, presentations, diagnosis, and management. Irish J Med Sci. 2024;193(2):677-88. DOI: https://doi.org/10.1007/s11845-023-03531-2
Paciaroni M, Bogousslavsky J. The history of stroke and cerebrovascular disease. Handbook of Clin Neurol. 2008;92:3-28. DOI: https://doi.org/10.1016/S0072-9752(08)01901-5
Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC). European Heart J Cardiovas Imag. 2022;23(10):333-465. DOI: https://doi.org/10.1093/ehjci/jeac106
Tyebally S, Chen D, Bhattacharyya S, Mughrabi A, Hussain Z, Manisty C, et al. Cardiac tumors: JACC cardio oncology state-of-the-art review. JACC Cardio Oncol. 2020;2(2):293-311. DOI: https://doi.org/10.1016/j.jaccao.2020.05.009
Kurnick A, Akivis Y, Sabu J, John S. Echocardiographic evaluation of cardiac masses. Current Cardiol Reports. 2023;25(10):1281-90. DOI: https://doi.org/10.1007/s11886-023-01945-z
Wang Q, Wang B, Zhang X, Zhong X, Chang S, Yang J, et al. The usefulness of contrast echocardiography in the evaluation of cardiac masses: a multicenter study. BMC Cardiovasc Disord. 2024;24(1):43. DOI: https://doi.org/10.1186/s12872-024-03708-2
Lestuzzi C. Primary tumors of the heart. Curr Opin Cardiol. 2016;31(6):593-8. DOI: https://doi.org/10.1097/HCO.0000000000000335
Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I, et al. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J American College of Cardiol. 2009;54(3):220-8. DOI: https://doi.org/10.1016/j.jacc.2009.05.006
Antoniak R, Kompa M, Burdach R, Grabowska-Derlatka L, Słowikowska A, Rowiński O. An atypical radiographic appearance of a cardiac myxoma: case report and review of the literature. Folia Morphol (Warsz). 2023;82(2):391-5. DOI: https://doi.org/10.5603/FM.a2022.0040
Wan Y, Du H, Zhang L, Guo S, Xu L, Li Y, et al. Multiple cerebral metastases and metastatic aneurysms in patients with left atrial Myxoma: a case report. BMC Neurol. 2019;19:1-6. DOI: https://doi.org/10.1186/s12883-019-1474-4
Gasparovic I, Artemiou P, Bezak B, Michut S, Hulman M. Surgery for cardiac myxomas: 12-year experience. Bratisl Lek Listy. 2023;124(9):635-8. DOI: https://doi.org/10.4149/BLL_2023_098
Amemiya K, Yonemoto Y, Ishibashi-Ueda H, Matsumoto M, Ohta-Ogo K, Ikeda Y, et al. Morphological characteristics of cardiac myxoma causing embolism: a series of 40 years of experience at a single institute. Virchows Archiv. 2023;482(2):377-84. DOI: https://doi.org/10.1007/s00428-022-03461-x